A. Demmer et al., LOCALIZATION OF THE IODOMYCIN BINDING-SITE IN HAMSTER P-GLYCOPROTEIN, The Journal of biological chemistry, 272(33), 1997, pp. 20913-20919
P-glycoprotein, the overexpression of which is a major cause for the f
ailure of cancer chemotherapy in man, recognizes and transports a broa
d range of structurally unrelated amphiphilic compounds, This study re
ports on the localization of the binding site of P-glycoprotein for io
domycin, the Bolton-Hunter derivative of the anthracycline daunomycin.
Plasma membrane vesicles isolated from multidrug-resistant Chinese ha
mster ovary B30 cells were photolabeled with [I-125]iodomycin. After c
hemical cleavage behind the tryptophan residues, I-125-labeled peptide
s were separated by electrophoresis and high performance liquid chroma
tography. Edman sequencing revealed that [I-125]iodomycin had been pre
dominantly incorporated into the fragment 230-312 of isoform I of hams
ter P-glycoprotein. According to models based on hydropathy plots, the
amino acid sequence 230-312 forms the distal part of transmembrane se
gment 4, the second cytoplasmic loop, and the proximal part of transme
mbrane segment 5 in the N-terminal half of P-glycoprotein. The binding
site for iodomycin is recognized with high affinity by vinblastine an
d cyclosporin A.